TURKISH JOURNAL OF HEMATOLOGY, cilt.35, sa.4, ss.290-295, 2018 (SCI-Expanded)
Objective: We aimed to find the incidence and risk factors of hematologic adverse effects of piperacillin-tazobactam (TZP).